superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-03-31
- Valid until
- 2023-06-30
- Published
- 2023-05-04
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 24,017,900,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Regeneron Pharmaceuticals total equity: 23,495,200,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_E4AE0A080B44, https://asof.is/claim/clm_E4AE0A080B44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm.
APA
AsOf. (2023). Regeneron Pharmaceuticals total equity: 23,495,200,000 United States dollar (as of 2023-03-31 (until 2023-06-30)) [Record clm_E4AE0A080B44]. Retrieved November 9, 2026, from https://asof.is/claim/clm_E4AE0A080B44 (source: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm)
BibTeX
@misc{asof_clm_E4AE0A080B44,
author = {AsOf},
title = {Regeneron Pharmaceuticals total equity: 23,495,200,000 United States dollar},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_E4AE0A080B44}},
note = {Claim clm\_E4AE0A080B44, as of 2023-03-31 (until 2023-06-30); source: https://www.sec.gov/Archives/edgar/data/872589/000180422023000016/0001804220-23-000016-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_E4AE0A080B44.md/v1/claims/clm_E4AE0A080B44submit a correction